Quest Diagnostics Incorporated Stock Price, News & Analysis (NYSE:DGX)

$91.62 -0.90 (-0.97 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$92.52
Today's Range$91.08 - $92.51
52-Week Range$86.89 - $112.96
Volume634,803 shs
Average Volume992,278 shs
Market Capitalization$12.61 billion
P/E Ratio16.58
Dividend Yield1.95%
Beta0.59

About Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Receive DGX News and Ratings via Email

Sign-up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DGX
CUSIP74834L10
Phone973-520-2700

Debt

Debt-to-Equity Ratio0.78%
Current Ratio1.47%
Quick Ratio1.37%

Price-To-Earnings

Trailing P/E Ratio16.58
Forward P/E Ratio16.22
P/E Growth1.93

Sales & Book Value

Annual Sales$7.52 billion
Price / Sales1.66
Cash Flow$6.65 per share
Price / Cash13.78
Book Value$35.42 per share
Price / Book2.59

Profitability

Trailing EPS$4.77
Net Income$645 million
Net Margins8.82%
Return on Equity15.53%
Return on Assets7.18%

Miscellaneous

Employees43,000
Outstanding Shares136,300,000

Frequently Asked Questions for Quest Diagnostics Incorporated (NYSE:DGX)

What is Quest Diagnostics Incorporated's stock symbol?

Quest Diagnostics Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."

How often does Quest Diagnostics Incorporated pay dividends? What is the dividend yield for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated announced a quarterly dividend on Friday, August 18th. Investors of record on Tuesday, October 3rd will be paid a dividend of $0.45 per share on Wednesday, October 18th. This represents a $1.80 annualized dividend and a dividend yield of 1.96%. The ex-dividend date is Monday, October 2nd. View Quest Diagnostics Incorporated's Dividend History.

How will Quest Diagnostics Incorporated's stock buyback program work?

Quest Diagnostics Incorporated declared that its board has approved a stock repurchase plan on Sunday, April 9th 2017, which authorizes the company to buyback $1,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 7.8% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its shares are undervalued.

How were Quest Diagnostics Incorporated's earnings last quarter?

Quest Diagnostics Incorporated (NYSE:DGX) posted its quarterly earnings data on Thursday, October, 19th. The medical research company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.35 by $0.04. The medical research company earned $1.93 billion during the quarter, compared to analysts' expectations of $1.92 billion. Quest Diagnostics Incorporated had a return on equity of 15.53% and a net margin of 8.82%. The company's revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.37 earnings per share. View Quest Diagnostics Incorporated's Earnings History.

When will Quest Diagnostics Incorporated make its next earnings announcement?

Quest Diagnostics Incorporated is scheduled to release their next quarterly earnings announcement on Wednesday, January, 24th 2018. View Earnings Estimates for Quest Diagnostics Incorporated.

Where is Quest Diagnostics Incorporated's stock going? Where will Quest Diagnostics Incorporated's stock price be in 2017?

19 brokerages have issued 12 month price objectives for Quest Diagnostics Incorporated's shares. Their forecasts range from $86.00 to $118.00. On average, they anticipate Quest Diagnostics Incorporated's share price to reach $104.42 in the next year. View Analyst Ratings for Quest Diagnostics Incorporated.

What are Wall Street analysts saying about Quest Diagnostics Incorporated stock?

Here are some recent quotes from research analysts about Quest Diagnostics Incorporated stock:

  • 1. According to Zacks Investment Research, "Quest Diagnostics’ third-quarter earnings topped the Zacks Consensus Estimate, while revenues remained in line. The company is currently focusing on its core diagnostic information services business and working on disciplined capital deployment. It is witnessing significant growth through infectious disease testing, prescription drug monitoring and wellness. Also several new collaborations with hospitals and integrated delivery networks continue to act as major growth drivers. We are looking forward to the recent partnership with Cleveland Clinic which includes the acquisition of Cleveland HeartLab. Over the last year, Quest Diagnostics was trading above the industry. On the flip side, the company faced major sales disruption in the third quarter due to the hurricanes. Accordingly, it has reduced the upper-end of its 2017 earnings guidance range which is disappointing. Tough competitive landscape and reimbursement headwind are other woes." (11/6/2017)
  • 2. Jefferies Group LLC analysts commented, "We are maintaining our Hold on DGX given our view that significant multiple expansion is unlikely from its current 10-year high P/E. That said, we do not expect its valuation to crack either given the company's stable fundamentals, the emerging opportunity with hospital labs, consistent dividend & buybacks, potential upside from US tax reform, and the composition of its shareholder base." (1/27/2017)

Who are some of Quest Diagnostics Incorporated's key competitors?

Who are Quest Diagnostics Incorporated's key executives?

Quest Diagnostics Incorporated's management team includes the folowing people:

  • Stephen H. Rusckowski, Chairman of the Board, President, Chief Executive Officer (Age 59)
  • Mark J. Guinan, Chief Financial Officer, Executive Vice President (Age 55)
  • James E. Davis, Executive Vice President, General Diagnostics (Age 54)
  • Michael E. Prevoznik, Senior Vice President, General Counsel (Age 55)
  • Jon Roger Cohen M.D., Senior Vice President, Group Executive - Diagnostic Solutions (Age 62)
  • Everett V. Cunningham, Senior Vice President - Commercial (Age 50)
  • Catherine T. Doherty, Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing (Age 54)
  • Carrie Eglinton Manner, Senior Vice President - Advanced Diagnostics (Age 42)
  • Daniel C. Stanzione Ph.D., Lead Independent Director (Age 71)
  • Jenne K. Britell Ph.D., Independent Director (Age 74)

Who owns Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock is owned by many different of retail and institutional investors. Top institutional investors include Macquarie Group Ltd. (5.05%), APG Asset Management N.V. (1.97%), Allianz Asset Management GmbH (1.49%), Dimensional Fund Advisors LP (1.49%), Victory Capital Management Inc. (1.41%) and Janus Henderson Group PLC (1.32%). Company insiders that own Quest Diagnostics Incorporated stock include Catherine T Doherty, Daniel Stanzione, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell, John B Ziegler, Michael E Prevoznik and Stephen H Rusckowski. View Institutional Ownership Trends for Quest Diagnostics Incorporated.

Who sold Quest Diagnostics Incorporated stock? Who is selling Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Capital International Investors, Bessemer Group Inc., Macquarie Group Ltd., First Trust Advisors LP, BNP Paribas Arbitrage SA, Cipher Capital LP and Russell Investments Group Ltd.. Company insiders that have sold Quest Diagnostics Incorporated company stock in the last year include Catherine T Doherty, Daniel Stanzione, Jeffrey M Leiden, Jenne K Britell, Michael E Prevoznik and Stephen H Rusckowski. View Insider Buying and Selling for Quest Diagnostics Incorporated.

Who bought Quest Diagnostics Incorporated stock? Who is buying Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Janus Henderson Group PLC, Victory Capital Management Inc., State Treasurer State of Michigan, Allianz Asset Management GmbH, Skandinaviska Enskilda Banken AB publ, Teacher Retirement System of Texas and Shell Asset Management Co.. View Insider Buying and Selling for Quest Diagnostics Incorporated.

How do I buy Quest Diagnostics Incorporated stock?

Shares of Quest Diagnostics Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quest Diagnostics Incorporated's stock price today?

One share of Quest Diagnostics Incorporated stock can currently be purchased for approximately $91.62.

How big of a company is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated has a market capitalization of $12.61 billion and generates $7.52 billion in revenue each year. The medical research company earns $645 million in net income (profit) each year or $4.77 on an earnings per share basis. Quest Diagnostics Incorporated employs 43,000 workers across the globe.

How can I contact Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated's mailing address is 500 PLAZA DRIVE, SECAUCUS NJ, 07940. The medical research company can be reached via phone at 973-520-2700 or via email at [email protected]


MarketBeat Community Rating for Quest Diagnostics Incorporated (DGX)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  274 (Thanks for Voting!)
Underperform Votes:  542 (Thanks for Voting!)
Total Votes:  816
MarketBeat's community ratings are surveys of what our community members think about Quest Diagnostics Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Quest Diagnostics Incorporated (NYSE:DGX)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.212.162.352.30
Ratings Breakdown: 2 Sell Rating(s)
15 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
15 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
12 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
11 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $106.18$106.83$107.75$103.03
Price Target Upside: 13.87% upside14.58% upside1.21% upside4.58% downside

Consensus Price Target History for Quest Diagnostics Incorporated (NYSE:DGX)

Price Target History for Quest Diagnostics Incorporated (NYSE:DGX)

Analysts' Ratings History for Quest Diagnostics Incorporated (NYSE:DGX)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/26/2017Canaccord GenuityBoost Price TargetBuy$100.00 -> $105.00N/AView Rating Details
10/20/2017Wells Fargo & CompanyLower Price TargetMarket Perform$88.00 -> $86.00N/AView Rating Details
10/20/2017Citigroup Inc.Lower Price TargetNeutral$110.00 -> $98.00N/AView Rating Details
10/19/2017MizuhoSet Price TargetBuy -> Buy$122.00 -> $103.00N/AView Rating Details
10/17/2017Craig HallumReiterated RatingHold$110.00 -> $100.00N/AView Rating Details
10/15/2017SunTrust Banks, Inc.Set Price TargetHold$105.00N/AView Rating Details
10/10/2017Goldman Sachs Group, Inc. (The)DowngradeConviction-Buy -> Buy$121.00 -> $113.00N/AView Rating Details
9/28/2017Credit Suisse GroupLower Price TargetNeutral$110.00 -> $99.00LowView Rating Details
9/25/2017Raymond James Financial, Inc.Reiterated RatingOutperform -> Market PerformHighView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$87.00 -> $92.00LowView Rating Details
7/25/2017Bank of America CorporationUpgradeNeutral -> Buy$111.00 -> $118.00MediumView Rating Details
7/25/2017Piper Jaffray CompaniesBoost Price TargetNeutral$107.00HighView Rating Details
7/19/2017Barclays PLCReiterated RatingHold$110.00LowView Rating Details
6/28/2017Evercore ISIReiterated RatingIn-Line$104.50LowView Rating Details
5/12/2017ArgusInitiated CoverageHold -> Hold$102.00LowView Rating Details
4/23/2017Deutsche Bank AGReiterated RatingBuy$108.00 -> $115.00LowView Rating Details
4/12/2017FBR & CoBoost Price TargetOutperform$103.00 -> $110.00LowView Rating Details
3/16/2017Jefferies Group LLCReiterated RatingHold$96.00MediumView Rating Details
6/24/2016Jyske BankDowngradeNeutral -> SellN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
4/22/2016Royal Bank Of CanadaBoost Price TargetSector Perform$70.00 -> $76.00N/AView Rating Details
1/29/2016William BlairReiterated RatingHoldN/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Quest Diagnostics Incorporated (NYSE:DGX)

Earnings by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Earnings History by Quarter for Quest Diagnostics Incorporated (NYSE DGX)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/24/2018$1.38N/AView Earnings Details
10/19/2017Q3 2017$1.35$1.39$1.92 billion$1.93 billionViewN/AView Earnings Details
7/25/2017Q2 2017$1.42$1.55$1.94 billion$1.94 billionViewN/AView Earnings Details
4/20/2017Q1 2017$1.18$1.33$1.87 billion$1.90 billionViewN/AView Earnings Details
1/26/2017Q416$1.27$1.31$1.86 billion$1.86 billionViewListenView Earnings Details
10/20/2016Q316$1.35$1.37$1.53 billion$1.89 billionViewListenView Earnings Details
7/21/2016Q216$1.32$1.34$1.91 billion$1.91 billionViewListenView Earnings Details
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details
1/29/2015Q414$1.05$1.08$1.85 billion$1.90 billionViewListenView Earnings Details
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details
10/17/2012$1.18$1.18ViewN/AView Earnings Details
7/19/2012$1.17$1.17ViewN/AView Earnings Details
4/18/2012$1.01$1.07ViewN/AView Earnings Details
1/24/2012$1.06$1.23ViewN/AView Earnings Details
10/25/2011$1.11$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$1.01$1.00ViewN/AView Earnings Details
1/25/2011$0.91$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX)
2017 EPS Consensus Estimate: $5.36
2018 EPS Consensus Estimate: $5.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.16$1.18$1.17
Q2 20175$1.39$1.43$1.42
Q3 20175$1.34$1.44$1.40
Q4 20175$1.36$1.39$1.38
Q1 20184$1.30$1.40$1.34
Q2 20184$1.47$1.56$1.53
Q3 20184$1.49$1.53$1.52
Q4 20184$1.43$1.46$1.45
Q1 20191$1.39$1.39$1.39
Q2 20191$1.58$1.58$1.58
Q3 20191$1.59$1.59$1.59
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Quest Diagnostics Incorporated (NYSE:DGX)

Most Recent Dividend:10/18/2017
Annual Dividend:$1.80
Dividend Yield:1.96%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:37.74% (Trailing 12 Months of Earnings)
31.86% (Based on This Year's Estimates)
31.25% (Based on Next Year's Estimates)
Track Record:5 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Dividend History by Quarter for Quest Diagnostics Incorporated (NYSE DGX)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/18/2017quarterly$0.451.72%10/2/201710/3/201710/18/2017
5/16/2017quarterly$0.451.71%7/6/20177/10/20177/24/2017
2/21/2017quarterly$0.451.88%4/3/20174/5/20174/19/2017
11/11/2016quarterly$0.451/6/20171/10/20171/25/2017
8/17/2016quarterly$0.401.88%9/30/201610/4/201610/19/2016
5/18/2016quarterly$0.402.1%7/1/20167/6/20167/20/2016
1/28/2016quarterly$0.402.31%4/4/20164/6/20164/20/2016
12/4/2015quarterly$0.382.22%1/8/20161/12/20161/27/2016
8/18/2015quarterly$0.382.07%10/2/201510/6/201510/21/2015
5/15/2015quarterly$0.382.09%7/6/20157/8/20157/22/2015
1/29/2015quarterly$0.382.13%4/6/20154/8/20154/22/2015
12/4/2014quarterly$0.332.03%1/9/20151/13/20151/28/2015
8/15/2014quarterly$0.332.14%10/3/201410/7/201410/22/2014
5/21/2014quarterly$0.332.3%7/7/20147/9/20147/23/2014
1/30/2014quarterly$0.332.51%4/4/20144/8/20144/23/2014
12/6/2013quarterly$0.301.99%1/3/20141/7/20141/22/2014
8/20/2013quarterly$0.302.03%9/27/201310/1/201310/16/2013
5/21/2013quarterly$0.301.96%6/28/20137/2/20137/17/2013
2/26/2013quarterly$0.302.14%3/28/20134/2/20134/16/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Quest Diagnostics Incorporated (NYSE DGX)

Insider Ownership Percentage: 1.75%
Institutional Ownership Percentage: 88.52%
Insider Trades by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)
Institutional Ownership by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Insider Trades by Quarter for Quest Diagnostics Incorporated (NYSE DGX)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2017Stephen H RusckowskiChairmanSell59,235$108.16$6,406,857.60View SEC Filing  
9/11/2017Daniel StanzioneDirectorSell40,900$108.07$4,420,063.00View SEC Filing  
9/11/2017Stephen H RusckowskiCEOSell53,933$108.16$5,833,393.28View SEC Filing  
9/5/2017Daniel StanzioneDirectorSell3,803$108.01$410,762.03View SEC Filing  
9/5/2017Stephen H RusckowskiChairmanSell2,525$108.03$272,775.75View SEC Filing  
8/4/2017Jeffrey M LeidenDirectorSell296$106.66$31,571.36View SEC Filing  
7/27/2017Jeffrey M LeidenDirectorSell1,304$108.73$141,783.92View SEC Filing  
6/19/2017Catherine T DohertySVPSell59,762$107.55$6,427,403.10View SEC Filing  
4/24/2017Jenne K BritellDirectorSell6,111$104.03$635,727.33View SEC Filing  
4/20/2017Michael E PrevoznikSVPSell29,513$100.00$2,951,300.00View SEC Filing  
3/16/2017Michael E PrevoznikSVPSell13,987$100.00$1,398,700.00View SEC Filing  
3/3/2017Catherine T DohertySVPSell7,162$98.28$703,881.36View SEC Filing  
2/27/2017Michael E PrevoznikSVPSell440$97.39$42,851.60View SEC Filing  
1/30/2017Catherine T DohertySVPSell80,000$90.58$7,246,400.00View SEC Filing  
8/19/2016Jenne K BritellDirectorSell4,000$84.76$339,040.00View SEC Filing  
8/10/2016Jenne K BritellDirectorSell4,000$85.20$340,800.00View SEC Filing  
8/3/2016Jeffrey M LeidenDirectorSell6,345$85.62$543,258.90View SEC Filing  
7/25/2016John B. ZieglerDirectorSell1,000$84.36$84,360.00View SEC Filing  
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18View SEC Filing  
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.00View SEC Filing  
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.12View SEC Filing  
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.00View SEC Filing  
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50View SEC Filing  
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.45View SEC Filing  
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.00View SEC Filing  
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.00View SEC Filing  
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.00View SEC Filing  
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.60View SEC Filing  
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.00View SEC Filing  
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.00View SEC Filing  
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.00View SEC Filing  
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.00View SEC Filing  
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.85View SEC Filing  
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.12View SEC Filing  
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Quest Diagnostics Incorporated (NYSE DGX)

Source:
DateHeadline
FY2018 EPS Estimates for Quest Diagnostics Incorporated Reduced by Analyst (DGX)FY2018 EPS Estimates for Quest Diagnostics Incorporated Reduced by Analyst (DGX)
www.americanbankingnews.com - November 23 at 4:30 PM
Quest Diagnostics Incorporated Forecasted to Earn Q1 2018 Earnings of $1.31 Per Share (DGX)Quest Diagnostics Incorporated Forecasted to Earn Q1 2018 Earnings of $1.31 Per Share (DGX)
www.americanbankingnews.com - November 23 at 10:55 AM
Q1 2018 EPS Estimates for Quest Diagnostics Incorporated Increased by KeyCorp (DGX)Q1 2018 EPS Estimates for Quest Diagnostics Incorporated Increased by KeyCorp (DGX)
www.americanbankingnews.com - November 22 at 10:16 AM
Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory TestsQuest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
www.prnewswire.com - November 20 at 5:55 PM
ETFs with exposure to Quest Diagnostics, Inc. : November 17, 2017ETFs with exposure to Quest Diagnostics, Inc. : November 17, 2017
finance.yahoo.com - November 17 at 1:17 PM
How Do Analysts See Quest Diagnostics Incorporated (DGX) Performing In The Year Ahead?How Do Analysts See Quest Diagnostics Incorporated (DGX) Performing In The Year Ahead?
finance.yahoo.com - November 16 at 6:28 PM
Quest Diagnostics Incorporated (DGX) Receives Consensus Recommendation of "Hold" from BrokeragesQuest Diagnostics Incorporated (DGX) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 16 at 2:30 PM
Quest Diagnostics, Clinical Genomics Ally, Oncology StrongQuest Diagnostics, Clinical Genomics Ally, Oncology Strong
finance.yahoo.com - November 14 at 6:20 PM
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
finance.yahoo.com - November 13 at 12:14 PM
Quest Diagnostics Sees Unusually High Options Volume (DGX)Quest Diagnostics Sees Unusually High Options Volume (DGX)
www.americanbankingnews.com - November 12 at 1:56 AM
Kindred Healthcare (KND) and Quest Diagnostics (DGX) Financial ReviewKindred Healthcare (KND) and Quest Diagnostics (DGX) Financial Review
www.americanbankingnews.com - November 11 at 3:28 PM
 Brokerages Expect Quest Diagnostics Incorporated (DGX) Will Post Quarterly Sales of $1.93 Billion Brokerages Expect Quest Diagnostics Incorporated (DGX) Will Post Quarterly Sales of $1.93 Billion
www.americanbankingnews.com - November 11 at 11:45 AM
 Analysts Expect Quest Diagnostics Incorporated (DGX) Will Announce Earnings of $1.40 Per Share Analysts Expect Quest Diagnostics Incorporated (DGX) Will Announce Earnings of $1.40 Per Share
www.americanbankingnews.com - November 9 at 5:22 AM
ETFs with exposure to Quest Diagnostics, Inc. : November 6, 2017ETFs with exposure to Quest Diagnostics, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 7:17 PM
Fresenius Medical (FMS) Q3 Earnings Miss, FY17 View IntactFresenius Medical (FMS) Q3 Earnings Miss, FY17 View Intact
finance.yahoo.com - November 6 at 7:17 PM
Quest Diagnostics Incorporated (DGX) Lifted to "Hold" at Zacks Investment ResearchQuest Diagnostics Incorporated (DGX) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 6 at 2:54 PM
Quest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology MeetingQuest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology Meeting
finance.yahoo.com - November 1 at 6:52 PM
Comparing Surgical Care Affiliates (SCAI) & Quest Diagnostics (DGX)Comparing Surgical Care Affiliates (SCAI) & Quest Diagnostics (DGX)
www.americanbankingnews.com - November 1 at 1:22 AM
Quest Diagnostics acquires California Laboratory AssociatesQuest Diagnostics acquires California Laboratory Associates
seekingalpha.com - October 30 at 7:20 AM
Quest Diagnostics Incorporated (DGX) Downgraded by Zacks Investment ResearchQuest Diagnostics Incorporated (DGX) Downgraded by Zacks Investment Research
www.americanbankingnews.com - October 27 at 1:44 PM
Quest Diagnostics Incorporated to Post FY2017 Earnings of $5.65 Per Share, SunTrust Banks Forecasts (DGX)Quest Diagnostics Incorporated to Post FY2017 Earnings of $5.65 Per Share, SunTrust Banks Forecasts (DGX)
www.americanbankingnews.com - October 27 at 8:50 AM
Quest Diagnostics Agrees To Acquire Cleveland HeartLab - Seeking AlphaQuest Diagnostics Agrees To Acquire Cleveland HeartLab - Seeking Alpha
seekingalpha.com - October 26 at 2:08 PM
Quest Diagnostics Incorporated Forecasted to Earn Q4 2017 Earnings of $1.38 Per Share (DGX)Quest Diagnostics Incorporated Forecasted to Earn Q4 2017 Earnings of $1.38 Per Share (DGX)
www.americanbankingnews.com - October 26 at 11:44 AM
DGX December 15th Options Begin TradingDGX December 15th Options Begin Trading
www.nasdaq.com - October 25 at 7:30 PM
ETFs with exposure to Quest Diagnostics, Inc. : October 25, 2017ETFs with exposure to Quest Diagnostics, Inc. : October 25, 2017
finance.yahoo.com - October 25 at 7:30 PM
Quest Diagnostics, Inc. :DGX-US: Earnings Analysis: Q3, 2017 By the Numbers : October 23, 2017Quest Diagnostics, Inc. :DGX-US: Earnings Analysis: Q3, 2017 By the Numbers : October 23, 2017
finance.yahoo.com - October 23 at 6:24 PM
Forbes Announces The Latest Winners Of The CIO Innovation AwardsForbes Announces The Latest Winners Of The CIO Innovation Awards
finance.yahoo.com - October 23 at 6:24 PM
Quest Diagnostics Incorporated (DGX) Expected to Post Q4 2017 Earnings of $1.39 Per ShareQuest Diagnostics Incorporated (DGX) Expected to Post Q4 2017 Earnings of $1.39 Per Share
www.americanbankingnews.com - October 23 at 5:20 AM
KeyCorp Research Analysts Cut Earnings Estimates for Quest Diagnostics Incorporated (DGX)KeyCorp Research Analysts Cut Earnings Estimates for Quest Diagnostics Incorporated (DGX)
www.americanbankingnews.com - October 23 at 4:22 AM
Quest Diagnostics Incorporated (DGX) Given Average Rating of "Hold" by AnalystsQuest Diagnostics Incorporated (DGX) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 22 at 2:50 PM
 Brokerages Anticipate Quest Diagnostics Incorporated (DGX) Will Announce Quarterly Sales of $1.92 Billion Brokerages Anticipate Quest Diagnostics Incorporated (DGX) Will Announce Quarterly Sales of $1.92 Billion
www.americanbankingnews.com - October 22 at 8:52 AM
Mizuho Reiterates $103.00 Price Target for Quest Diagnostics Incorporated (DGX)Mizuho Reiterates $103.00 Price Target for Quest Diagnostics Incorporated (DGX)
www.americanbankingnews.com - October 21 at 4:44 PM
Head-To-Head Analysis: Kindred Healthcare (KND) & Quest Diagnostics (DGX)Head-To-Head Analysis: Kindred Healthcare (KND) & Quest Diagnostics (DGX)
www.americanbankingnews.com - October 21 at 4:34 PM
Quest Diagnostics Incorporated (DGX) Price Target Cut to $98.00Quest Diagnostics Incorporated (DGX) Price Target Cut to $98.00
www.americanbankingnews.com - October 21 at 11:48 AM
Quest Diagnostics Incorporated (DGX) PT Lowered to $86.00 at Wells Fargo & CoQuest Diagnostics Incorporated (DGX) PT Lowered to $86.00 at Wells Fargo & Co
www.americanbankingnews.com - October 21 at 12:38 AM
Reviewing China Cord Blood Corporation (CO) and Quest Diagnostics (DGX)Reviewing China Cord Blood Corporation (CO) and Quest Diagnostics (DGX)
www.americanbankingnews.com - October 21 at 12:26 AM
Zacks: Analysts Expect Quest Diagnostics Incorporated (DGX) to Announce $1.39 EPSZacks: Analysts Expect Quest Diagnostics Incorporated (DGX) to Announce $1.39 EPS
www.americanbankingnews.com - October 20 at 10:34 AM
Edited Transcript of DGX earnings conference call or presentation 19-Oct-17 12:30pm GMTEdited Transcript of DGX earnings conference call or presentation 19-Oct-17 12:30pm GMT
finance.yahoo.com - October 19 at 11:35 PM
Quest Diagnostics Cuts FY17 EPS View, Updates Sales Forecast On Hurricane ImpactQuest Diagnostics Cuts FY17 EPS View, Updates Sales Forecast On Hurricane Impact
www.rttnews.com - October 19 at 6:31 PM
Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term OutlookQuest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook
finance.yahoo.com - October 19 at 6:31 PM
Quest Diagnostics tops Street 3Q forecastsQuest Diagnostics tops Street 3Q forecasts
finance.yahoo.com - October 19 at 6:31 PM
Quest Diagnostics (DGX) Tops Q3 Earnings, Revenues In LineQuest Diagnostics (DGX) Tops Q3 Earnings, Revenues In Line
finance.yahoo.com - October 19 at 6:31 PM
Quest Diagnostics: Proposed lab test cuts wont hurt outlookQuest Diagnostics: Proposed lab test cuts won't hurt outlook
finance.yahoo.com - October 19 at 6:31 PM
Quest Diagnostics (DGX) Beats Earnings in Q3, Updates ViewQuest Diagnostics (DGX) Beats Earnings in Q3, Updates View
finance.yahoo.com - October 19 at 6:31 PM
Quest Diagnostics Incorporated (DGX) Issues Quarterly  Earnings Results, Misses Estimates By $0.04 EPSQuest Diagnostics Incorporated (DGX) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - October 19 at 9:50 AM
Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland ClinicQuest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
finance.yahoo.com - October 18 at 7:19 PM
Quest Diagnostics Incorporated (DGX) Receives "Hold" Rating from Craig HallumQuest Diagnostics Incorporated (DGX) Receives "Hold" Rating from Craig Hallum
www.americanbankingnews.com - October 17 at 10:08 AM
Quest Diagnostics (DGX) versus The Competition Critical AnalysisQuest Diagnostics (DGX) versus The Competition Critical Analysis
www.americanbankingnews.com - October 16 at 10:30 AM
Brokers Issue Forecasts for Quest Diagnostics Incorporateds Q3 2017 Earnings (DGX)Brokers Issue Forecasts for Quest Diagnostics Incorporated's Q3 2017 Earnings (DGX)
www.americanbankingnews.com - October 16 at 2:38 AM
Quest Diagnostics Incorporated (DGX) Research Coverage Started at Wells Fargo & CompanyQuest Diagnostics Incorporated (DGX) Research Coverage Started at Wells Fargo & Company
www.americanbankingnews.com - October 15 at 8:31 AM

Social Media

Financials

Chart

Quest Diagnostics Incorporated (NYSE DGX) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.